Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569490 · ClinicalTrials.gov registry record · NA
Striving to Quit: First Breath
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 3,100
- Enrollment target
NCT01569490: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT01569490 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 3,100 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (121% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01569490, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,100 participants
- Enrollment target
Study Summary
This study is designed to test the hypotheses that incentives can increase both participation in smoking cessation treatment and resulting cessation rates, when they are offered to Medicaid BadgerCare Plus pregnant smokers.
Primary Outcome
The data will be the biochemically confirmed reports of abstinence for the past 7 days (i.e., 7-day point-prevalence abstinence)
Interventions
- BEHAVIORAL Incentives for abstinence and treatment engagement
- BEHAVIORAL Attendance incentive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,100 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT01569490 record still lists
NCT01569490 is an interventional study that assigns participants to a tested intervention. Its 3,100 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (121% higher).
The record links to 0 conditions, and to 2 interventions - of which Incentives for abstinence and treatment engagement is the first listed.
NCT01569490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01569490 about?
NCT01569490 is a clinical study titled "Striving to Quit: First Breath". This study is designed to test the hypotheses that incentives can increase both participation in smoking cessation treatment and resulting cessation rates, when they are offered to Medicaid BadgerCare Plus pregnant smokers.
What is the current status of trial NCT01569490?
This trial is currently completed. It is a NA study. The enrollment target is 3,100 participants. The study started on 2012-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01569490?
The interventions under investigation include: Incentives for abstinence and treatment engagement (BEHAVIORAL), Attendance incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT01569490?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01569490's enrollment target sits among peer trials
3,100 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia